- Foam enema 10% (£9.33 = 14 application canister)
- Hydrocortisone foam enema should be considered as the first line steroid rectal foam
- Budenofalk® capsules containing e/c granules 3mg (£75.05 = 100 capsules)
- Budenofalk® 2mg/dose rectal foam (£57.11 = 14 application canister)
- Capsules are included for induction of remission in mild or moderate ileocaecal Crohn's disease. Treat for up to 8 weeks - reduce dose in last two weeks of treatment
- Rectal foam is included for Ulcerative colitis
- Consider Budenofalk® rectal foam as a second line alternative to hydrocortisone foam enema
- Retention enema 20mg in 100ml (£7.50 = 7 enemas)
- Suppositories 5mg (£55.47 = 10 suppositories)
Budesonide prolonged release (Cortiment®)
Not routinely commissioned for use in NEW Devon CCG and South Devon and Torbay CCG, following consideration by the clinical policy committee. Click here for more information. The policy indicates that in exceptional circumstances the Trust-Managed Individual Patient Treatments process can be used.
Corticosteroids in Inflammatory Bowel Disease (IBD)
- Before starting steroids consider carefully if symptoms are due to active disease or other diagnosis e.g. co-existing irritable bowel syndrome. A raised CRP may help to confirm active disease.
- Avoid ultra-short or low doses. For the majority of patients start at prednisolone 40mg and decrease over 8 weeks.
- Steroids have no role in maintenance therapy.
- At one year, approximately 50% of patients with ulcerative colitis will be steroid dependent or steroid refractory.
Decision to start immunomodulator therapy for patients with ulcerative colitis will be made by gastroenterologist, typically if:
- More than 1 course of steroids in any 2 year period
- Following any severe attack requiring IV steroids
1. Gastrointestinal >
1.5 Chronic bowel disorders >
- First line
- Second line